RAPTOR PHARMACEUTICAL CORP COM STK (DE)
RPTP
RPTP was delisted on the 24th of October, 2016.
82 hedge funds and large institutions have $289M invested in RAPTOR PHARMACEUTICAL CORP COM STK (DE) in 2014 Q3 according to their latest regulatory filings, with 17 funds opening new positions, 21 increasing their positions, 28 reducing their positions, and 9 closing their positions.
89% more first-time investments, than exits
New positions opened: 17 | Existing positions closed: 9
11% more funds holding
Funds holding: 74 → 82 (+8)
20% less capital invested
Capital invested by funds: $359M → $289M (-$70.5M)
25% less repeat investments, than reductions
Existing positions increased: 21 | Existing positions reduced: 28
56% less call options, than puts
Call options by funds: $6.53M | Put options by funds: $14.7M
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
CS
Credit Suisse
Zurich,
Switzerland
|
+$7.92M |
| 2 |
Point72 Asset Management
Stamford,
Connecticut
|
+$4.27M |
| 3 |
PAMU
Pictet Asset Management (UK)
London,
United Kingdom
|
+$3.61M |
| 4 |
EAM
EverPoint Asset Management
Stamford,
Connecticut
|
+$3.32M |
| 5 |
Axa
Paris,
France
|
+$1.93M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Goldman Sachs
New York
|
-$20.5M |
| 2 |
Lord, Abbett & Co
Jersey City,
New Jersey
|
-$4.44M |
| 3 |
Group One Trading
Chicago,
Illinois
|
-$3.78M |
| 4 |
Jane Street
New York
|
-$2.96M |
| 5 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$2.18M |
RPTP Hedge Fund Activity: Q3 2014 in Review
82 of the 3,447 institutional investors tracked by Wall St. Rank reported a position in RAPTOR PHARMACEUTICAL CORP COM STK (DE) (RPTP) for Q3 2014, worth a combined $289M — down 20% from $359M a quarter earlier.
Buyers outnumbered sellers: 17 funds opened new RPTP positions and 9 closed out — a net gain of 8 holders — while 21 added to existing stakes and 28 trimmed.
The largest buyer was Credit Suisse, adding an estimated $7.92M. The largest seller was Goldman Sachs, cutting an estimated $20.5M.
- 82 institutional investors held RAPTOR PHARMACEUTICAL CORP COM STK (DE) (RPTP) as of Q3 2014, up from 74 in Q2 2014.
- Funds reported $289M of RAPTOR PHARMACEUTICAL CORP COM STK (DE) stock for Q3 2014, down 20% quarter-over-quarter.
- 17 funds opened new RAPTOR PHARMACEUTICAL CORP COM STK (DE) positions in Q3 2014 and 9 closed out, a net change of +8 holders.
- The largest RAPTOR PHARMACEUTICAL CORP COM STK (DE) buyer in Q3 2014 was Credit Suisse, an estimated $7.92M added.
- The largest RAPTOR PHARMACEUTICAL CORP COM STK (DE) seller in Q3 2014 was Goldman Sachs, an estimated $20.5M sold.
Based on aggregated 13F filings for Q3 2014.